Login to Your Account

Other News To Note

Tuesday, May 21, 2013
• Asmacure Ltee, of Quebec City, reported findings from four studies of ASM-024, its lead compound for asthma and chronic obstructive pulmonary disease (COPD), at the 2013 American Thoracic Society International Conference in Philadelphia.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription